Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy
出版年份 2016 全文链接
标题
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy
作者
关键词
-
出版物
Cancer Biomarkers
Volume 17, Issue 1, Pages 33-40
出版商
IOS Press
发表日期
2016-07-13
DOI
10.3233/cbm-160614
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
- (2016) Hee Seung Kim et al. Cancer Research and Treatment
- Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients
- (2015) Wei-wei Zhang et al. TUMOR BIOLOGY
- Postoperative Time Course and Utility of Inflammatory Markers in Patients with Ovarian Peritoneal Carcinomatosis Treated with Neoadjuvant Chemotherapy, Cytoreductive Surgery, and HIPEC
- (2014) F. J. Medina Fernández et al. ANNALS OF SURGICAL ONCOLOGY
- Comparison of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios for Predicting Malignant Potential of Suspicious Ovarian Masses in Gynecology Practice
- (2014) Hasan Onur Topcu et al. Asian Pacific Journal of Cancer Prevention
- Roles of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios in the Early Diagnosis of Malignant Ovarian Masses
- (2014) Mem Arjen Yildirim et al. Asian Pacific Journal of Cancer Prevention
- Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
- (2014) Ying Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer
- (2014) In Rae Cho et al. Gastric Cancer
- “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?
- (2014) Alison Davis et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer
- (2014) Kristina A. Williams et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
- (2014) Peng Xue et al. Cancer Medicine
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
- (2013) Suee Lee et al. BMC CANCER
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
- (2012) Hyuk-Chan Kwon et al. BIOMARKERS
- Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
- (2012) Supachai Raungkaewmanee et al. Journal of Gynecologic Oncology
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
- (2011) Basem Azab et al. ANNALS OF SURGICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
- (2011) Viren Asher et al. Clinical & Translational Oncology
- Use of Inflammatory Markers to Guide Cancer Treatment
- (2011) S J Clarke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
- (2008) HanByoul Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started